Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram. AL = artemether–lumefantrine; AQ = amodiaquine; AS = artesunate; AZ = azithromycin; DP = dihydroartemisinin–piperaquine; IPTi = intermittent preventive treatment in infancy; SMC = seasonal malaria chemoprevention; SP = sulfadoxine–pyrimethamine.